Machine-learned diagnosis models have shown promise as medical aides but are trained under a closed-set assumption, i.e. that models will only encounter conditions on which they have been trained. However, it is practically infeasible to obtain sufficient training data for every human condition, and once deployed such models will invariably face previously unseen conditions. We frame machinelearned diagnosis as an open-set learning problem, and study how state-of-the-art approaches compare. Further, we extend our study to a setting where training data is distributed across several healthcare sites that do not allow data pooling, and experiment with different strategies of building open-set diagnostic ensembles. Across both settings, we observe consistent gains from explicitly modeling unseen conditions, but find the optimal training strategy to vary across settings. * Work done as research intern at Curai. † Work done as advisor to Curai. 3 Though some codes can be collapsed due to clinical similarity, the actual number is still in a few thousands.
Introduction
An increasing number of adults in the US are turning to the internet to find answers to their medical concerns. A survey conducted in Semigran et al. [2015] revealed that in 2012, 35% of U.S. adults had gone online at least once to self-diagnose. In fact, around 7% of Google's daily searches are health related [Murphy, 2019] .
To service this need, several online "symptom checking" services have emerged, which typically first ask patients a series of questions about their symptoms, and then provide a diagnosis. These services can improve both accessibility as well as provide patients with directed information to guide their medical decision-making [Semigran et al., 2015] . Symptom checkers are increasingly powered by machine-learned diagnosis models. These models are not only showing promise as potential decision aides for patients and medical professionals alike but are also poised to revolutionize patient-facing telehealth services that could move from the current rules-based protocols for nurse hotlines to more accurate and scalable AI systems.
Existing models for clinical decision support (CDS) make a closed-world assumption i.e. the universe of diseases is limited to those that have been encoded in the model. In practice, it is likely that a deployed diagnosis model will encounter previously unseen conditions rendering the original assumption unrealistic. Not only is the number of possible diagnoses very large (over 14025 diagnosis codes exist in ICD 9/10 3 ), but obtaining sufficient training data for each condition is also challenging. As a result, many telehealth providers constrain the coverage of their CDS system to specific areas of care. However, determining whether or not a patient falls within diagnostic scope based on symptoms alone necessitates employing additional models or human expertise, which can be both challenging and expensive. Further, each misdiagnosis is a missed opportunity for better care, and can even be safety-critical in some cases. The goal is to learn a model to diagnose diseases from L select and reject unseen conditions ∈ L unknown given a training set of diseases L select , and optionally additional data from L extra . Right: Ensembled Open Set Diagnosis. In this setting, the goal and evaluation setting is identical to the previous task but training data is now distributed across multiple sites. See § 2 for more details.
Prior work in machine learning has studied the open-set learning problem (and the related problem of learning with a reject option), which is concerned with developing approaches that are aware of and can avoid misclassifying previously unseen classes [c.f Chow [1970] , Bendale and Boult [2015] ]. In this work, we frame diagnosis as an open-set classification problem, and compare the efficacy of different approaches.
Another critical challenge in building diagnosis models is access to data. Health data usually lives in hospital repositories and for privacy reasons, can often not be taken outside its respective source site to be pooled with other sources. This makes training models (particularly data-inefficient neural networks) hard. Further, different healthcare sites may have complementary data -for instance, electronic health records (EHR) of tropical countries are more likely to contain a lot more clinical cases for malaria than the rest of the world. Similarly, hospitals on the US east coast are likely to have more patient encounters for hypothermia than on the west. To develop comprehensive and accurate models that cover a wide range of diseases, we need mechanisms to bridge models trained on these individual sites. To this end, we introduce the task of Ensembled Open Set Diagnosis, where we compare methods to ensemble models trained on data sources that cannot be shared, and evaluate their open-set diagnostic performance. While this setup has widespread applicability in healthcare, to the best of our knowledge we are the first to study it.
Our contributions are two-fold:
1. We frame machine-learned diagnosis as an open-set learning problem, and study how well existing approaches to open-set learning translate to clinical diagnosis. We find that a simple approach (using an additional "background" class) outperforms a state-of-the-art open-set learning. Moreover, approaches that explicitly account for unseen conditions consistently outperform baselines that do not. 
Setup
Let Y represent the universe of all possible human diseases that can be diagnosed. Let L select ⊂ Y represent a subset of diseases for which we have labeled data and wish to include within the scope of diagnosis of our model. For instance, in a telehealth setting, L select could correspond to the subset of diseases that can easily be diagnosed remotely. However, once deployed, this model might encounter cases belonging to any disease D ∈ Y. Our objective is to develop a model that can correctly diagnose diseases belonging to L select , and declare NOTA (none of the above) otherwise.
Let U = Y \ L select be the set of all possible conditions that our model needs to reject, i.e. declare NOTA. We further divide U = L unknown ∪ L extra where L unknown ∩ L extra = ∅, with L extra representing some additional "extra" conditions that are outside the scope of diagnosis, but for which we may have some small amount of training data. We can view L extra as a proxy for unseen classes during training.
Note, importantly, that cases corresponding to L unknown are only seen at test time. In a telehealth medical setting, L unknown may correspond to the set of conditions that are rare or challenging to obtain training data for, but that the model might potentially encounter once deployed. In this openset setting, we want to prevent misdiagnosis and instead recommend additional diagnostic evaluation such as a physical examination, laboratory tests, or imaging studies.
We study two experimental tasks within this setting:
Task 1: Open Set Diagnosis. In this task (see Fig 1, left) , we assume centralized access to training data, and attempt to learn a medical diagnosis model that can accurately diagnose a given clinical case as either one of L select , or as NOTA (none of the above).
Task 2: Ensembled Open Set Diagnosis. In this task (see Fig 1, right), we assume that training data is distributed across K sites (say a hospital, a clinic, and a specialty lab) that do not allow data-pooling. Each site is provided with clinical case data spanning a label set L i and trains a corresponding expert model M i . Each L i comprises of a relevant subset L i rel ⊂ L select , and optionally an 'extra' subset L iextra ∩ L select = φ. As shown in Fig. 1 , these label spaces may have overlap. The goal is to train an ensemble model of these individual experts that is capable of diagnosing L select clinical conditions, while avoiding misdiagnosis of conditions in L unknown .
Approach
We experiment with three approaches to open-set classification -"vanilla" softmax cross-entropy with thresholding, training an explicit "background" class, and a recently proposed state-of-the-art approach based on neural network "agnostophobia" [Dhamija et al., 2018] .
Models for Open Set classification
Cross-entropy (CE) loss with confidence thresholding: In this approach (c.f. Matan et al. [1990] , Fumera and Roli [2002] ), a classification model f : X → L select is learned. Assuming that the model will have high predictive softmax entropy for datapoints belonging to previously unseen classes, all datapoints for which the model's confidence falls below a threshold θ (picked using a validation set) are classified as NOTA. In particular, for input x, with predicted probability distribution, P (c|x), a prediction c * is made as follows:
Background (BG) class: In this line of work, an explicit 'background' class is included as a catch-all class for modeling out-of-domain inputs. An assumption here is the availability of a set of examples that are sufficiently representative of unknown classes. In our setup, this would mean training a classifier f : X → L select + 1 where the NOTA i.e. background class is trained using data from L extra as a proxy for unseen classes.
Entropic Open-set (EOS) Loss: Introduced in Dhamija et al. [2018] , this loss encourages high predictive entropy for examples corresponding to unseen classes. Similar to the previous approach, L extra is used as a proxy for unseen conditions at training time. Thus, a classifier f : X → L select is learned with the entropic loss J eos defined for datapoint (x, c) as follows:
The intuition is to encourage high predictive entropy on unseen (i.e. L extra ) examples, and train with regular cross-entropy on seen examples. Similar to CE, prediction follows Eq. 1 and NOTA is predicted via confidence thresholding. We also tried the Objectosphere loss [Dhamija et al., 2018] that builds on EOS by additionally encouraging a margin between feature activation magnitudes for knowns and unknowns, but did not observe performance gains. In our experiments we present results using the EOS loss.
Another applicable line of work compared to in Dhamija et al. [2018] are approaches that explicitly model network uncertainty [Gal and Ghahramani, 2016, Lakshminarayanan et al., 2017] . However, they find the CE, BG, and EOS approaches to significantly outperform such a baseline (specifically, deep ensembles proposed in Lakshminarayanan et al. [2017] ) on the open set classification task.
As a result, we do not study these in our paper. Further, as the same work points out, uncertainty estimation is an orthogonal approach that can potentially be combined with the approaches we study.
Ensembling strategies
To ensemble diagnosis models trained on different sites (Task 2), we experiment with two strategies:
Max-confidence (naive): We predict the class with highest confidence as the ensemble prediction. For experts trained with BG, we average confidence for the background class across experts.
Mixture of Experts (learned):
We assume access to a very small set of pooled and previously heldout training data for training an ensemble. This dataset can come from each site sharing a small amount of de-identified data, or through manual curation of clinical cases. In this setup, we parameterize our ensemble with a "mixture of experts" [Jacobs et al., 1991] architecture that makes use of a fully connected (FC) layer as a gating function over the current input, that is elementwise multiplied with a concatenation of logits from each expert for the same input, and passed through another FC layer. We experiment with CE, BG, and EOS losses for training this learned ensemble.
4 Experimental Setup
Clinical case simulation
We simulate a large number of clinical vignettes from a medical decision expert system [Miller et al., 1982] to use as our dataset. The expert system has a knowledge base of diseases, findings (covering symptoms, signs, and demographic variables), and their relationships. Relationships between finding-disease pairs are encoded as evoking strength and frequency, with the former indicating the strength of association between the constituent finding-disease pair and the latter representing frequency of the symptom in patients with the given disease. Further, disease prevalence metadata suggests whether a given disease is very common, common, or rare.
The simulation algorithm [Parker and Miller, 1989, Ravuri et al., 2018 ] makes a closed world assumption with the universe of diseases (denoted Y) and findings (F ) being those in the knowledge base. The simulator first samples a disease d ∈ Y and demographic variables, and then samples findings in proportion to frequency for the picked disease. Each sampled finding is assigned to be present or absent, based on frequency. If assigned present, then findings that are impossible to cooccur are removed from consideration (e.g. a person cannot have both productive and dry cough).
The simulation for a case ends when all findings in the knowledge base have been considered. At the end of the simulation, a clinical case is a pair (x, d) where d ∈ Y is the diagnosis and x captures the instantiated finding. In particular, each element x j is a binary variable of finding presence. For our experiments, we limit to demographic variables and symptoms as these are the most likely available findings when first diagnosing a patient in a telehealth setting; we also restrict cases to 5-8 symptoms reflecting a typical clinical case.
Dataset construction
Constructing L select , L unknown and L extra : As most telehealth services are likely to include common conditions within diagnostic scope, we choose L select to be the 160 diseases marked as "very common" in the knowledge base of the clinical case simulator described above. Further, recall that we want to be robust to misdiagnosis of previously unseen and possibly rare conditions, including (and especially) those with high symptom overlap with seen L select . Therefore, we construct a challenging L unknown split as follows: First, we average one-hot encodings (using a D = 2052 dimensional vocabulary) of the cases for all (=830) diseases in our knowledge base. Then, we apply dimensionality reduction via principal component analysis on this N × D dimensional matrix, retaining D = 500 components that explain 90% of total variance. We pick the first unique nearest neighbor to each condition in L select to yield 160 unseen conditions that have high finding overlap with L select . This constitutes our L unknown set of diseases. Finally, 160 diseases corresponding to L extra are chosen uniformly at random from the set of conditions that remain.
An example of a challenging (disease, distractor) pair between L select and L unknown that we obtain via the scheme described is 'Amblyopia' (lazy eye) and 'Diabetic Ophthalmoplegia' -both conditions are vision impairments (often, double vision problems) that lead to blurred vision. Another pair is 'Actinic Keratosis' and 'Melanoma', where the former is a scaly patch on the skin due to prolonged sun exposure, while melanoma manifests as an unusual skin growth. Yet another example is ('Melancholia', 'Bipolar disorder') both of which share symptoms such as depressed moods and anxiety, except that bipolar disorder tends to be episodic and requires longitudinal insight.
Data split for Task 1. We simulate clinical cases employing the strategy described in §. 4.1. For diseases in L select , we simulate 1000 cases per condition. From this, we use 20% for testing (D select ), and the remaining 80% (D select ) for training and validation. To mimic the difficulty of obtaining training data for less common conditions, we only simulate 100 cases on average for each condition in L extra , and use it for training BG and EOS models. Finally, we simulate 1000 cases for each condition in L unknown to obtain D unknown . We report performance over our test set constructed as D select D unknown .
Data split for Task 2. For this setting, we simulate a realistic distribution of data among M = 4 individual healthcare sites. As previously discussed, each site contributes cases spanning a subset of relevant diseases L i rel ⊂ L select . We achieve this by dividing L select (from Task 1) across the M sites, and vary the degree of overlap between different sites. We define overlap as the number of conditions that occur in > 1 sites, as a % of |L select |. Further, each site also contributes "extra" diseases L iextra ⊂ L select that are out of the target diagnostic scope. We pick conditions uniformly at random from the set of remaining conditions as L iextra .
Metrics
For open-set diagnosis, we use the Open-Set Classification Rate (OSCR) metric proposed in Dhamija et al. [2018] , which plots false positive rate (FPR) versus correct classification rate (CCR) as a function of confidence threshold θ: 
Base Model
For Task 1, we parameterize models as 2-layer Multilayer Perceptrons (MLP's) with one-hot feature encodings, using a global vocabulary constructed from the union of all case findings. We use ReLU non-linearities and 100 hidden units. As in Dhamija et al. [2018] , we set bias terms in the logit i.e. second hidden layer to 0. For ensemble models (Task 2), we employ the same architecture for individual site models (experts), but assume access to a single shared vocabulary of symptoms; however, symptoms may be missing across different sites because of the data available to that site. 
Results
All models are trained with early stopping based on validation loss. We use an initial learning rate of 10 −3 and use Adam optimization [Kingma and Ba, 2014] . Further, since L extra is sampled randomly, and to ensure statistical significance, we train models over three random samplings of L extra and report performance means and standard deviations.
Task 1: Open Set diagnosis
To study the difference between different algorithms, we choose an operating threshold corresponding to FPR values of 10-30%, and report the corresponding CCR. This choice allows capturing an important trade-off; in our setting, we assume that it is better to misclassify a known "common" disease as unknown (NOTA) than to misdiagnose an unknown "rare" disease as known (one of L select ). Further, we note that while our choice of operating false positive rates appears large, they are commensurate with our extremely challenging and large (> 204k examples) test set. Table 1 compares different methods at three different FPR values. We can see that methods that explicitly model unseen classes perform better than methods that do not. Interestingly, and in contrast to the findings in Dhamija et al. [2018] , we find BG to outperform EOS in this setting 4 . The OSCR curve in Figure 2 corroborates this trend across thresholds. These results suggest that, consistent with prior work, explicitly modeling out-of-distribution conditions is beneficial when the test time evaluation is open set, though the optimal choice of modeling strategy may be task dependent. Table 2 compares the performance corresponding to the two methods for ensembling individual experts (with different loss functions) trained at various sites. Additionally, as a performance upper bound, for each setting we also mark the performance of an "oracle" BG model that has centralized access to all the training data.
Task 2: Ensembled Open Set Diagnosis
We observe that across all approaches, models that explicitly model unseen conditions (BG and EOS) consistently outperform those that do not (CE). Further, we notice opposing trends across the naive and learned ensembles -in the former, BG significantly outperforms EOS (row 2 vs 3), while in the latter we observe the converse (row 5 vs 6).
Training the learned ensemble with the EOS loss on top of experts trained with BG appears to improve mean performance, but doing so with the EOS loss does not (rows 7-9). Finally, in both naive and learned cases, the oracle significantly outperforms all approaches, with the gap representing the error introduced by the distributed training and ensembling.
In Fig. 3 , we present OSCR curves for our studied approaches. Clearly, different models have different starting operating points for FPR. We further break down errors for known examples (i.e. CCR performance) into misclassification as background vs as an incorrect foreground class. For instance, we find the 24.01% CCR error@FPR=0.1 for (1 of 3 runs of) our learned EOS+BG model breaks down as 23.54% and 0.47%, respectively. We find similar trends to hold across approaches. Clearly, the model is very accurate at distinguishing between classes it has been trained on, but still struggles with consistently rejecting previously unseen conditions. In Fig. 5 .2, we plot the histograms of softmax entropy over our test set from the learned CE+CE, BG+CE, and EOS+CE models. As expected, we find that models trained with EOS losses have higher predictive entropy for unseen examples. Note that we do not observe a completely clear separation even with the EOS loss, which we attribute to the difficulty of our test set.
Varying overlap. We study performance at 0%, 50%, and 100% overlap (number of conditions that occur in > 1 sites, as a % of |L select |). Correspondingly, the number of conditions per expert ranges from |L select |/M = 40 conditions (0% overlap) to 80 (100% overlap). As seen in Table 3 , we observe near-consistent trends across all degrees of overlap.
Qualitative examples. Fig. 4 Table 4 : Sample model predictions. Columns 1-2 represent the case findings and ground truth condition, while columns 3-6 show predictions across models, either as top-3 predictions (and corresponding scores), or NOTA. We color code correct predictions in green and incorrect ones in red.
atopic dermatitis and patchy hair loss, most models appear to ignore patchy hair loss (main indicator of 'alopecia areata'), and focus on the sudden onset of 'atopic dermatitis'. Similarly, the clinical vignette corresponding to 'atrial flutter' (also in L unknown ) is misdiagnosed as 'atrial fibrillation'. In fact, atrial fibrillation and atrial flutter tend to often co-occur [Horvath et al., 2000] , and so patient symptoms may not be sufficient to differentiate the two. This also sheds light on the complexity of medical diagnosis when multiple diseases share symptoms and also co-manifest in a patient.
Closed-set diagnosis. Lastly, we measure closed-set diagnostic performance i.e. evaluate on a test set consisting of heldout examples from L select alone (=31,000 examples). We use recall@k as our metric. We find that for both naive and learned settings, all approaches perform similarly. We also find this to hold true across degrees of overlap. For example, naive CE, BG, and EOS achieve {92.05, 99.1}, {92.37, 99.23}, and {90.91, 99.18} recall@{1, 3} respectively at 50% overlap. We conclude that explicitly modeling unseen conditions does not adversely affect closed-set performance.
Related Work
Machine-learning for diagnosis. A number of works have proposed machine-learned diagnostic models [Wang et al., 2014 , Miotto et al., 2016 , Ling et al., 2017 , Shickel et al., 2017 , Rajkomar et al., 2018 , Liang et al., 2019 , Ravuri et al., 2018 . Rajkomar et al. [2018] propose a deep neural architecture to predict ICD codes from both structured and clinical notes in EHR, while Liang et al.
[2019] introduce a model for predicting ICD codes for pediatric diseases. Ravuri et al. [2018] present an approach to combine knowledge from a clinical medical expert system with electronic health records to learn models for diagnosis. Across prior work, the space of diseases considered is fixed across train and test.
Learning with reject option. The problem of learning with an additional reject option has a long history in the literature [Chow, 1970 , Herbei and Wegkamp, 2006 , Bartlett and Wegkamp, 2008 , and recent work has extended this to deep networks under various frameworks. Bendale and Boult [2015] frame the problem as one of open-set learning, and propose an additional OpenMax layer that explicitly estimates the probability of a datapoint being from an unseen class. Others have studied this problem as one of detecting (and rejecting) out-of-distribution test datapoints (or outlier rejection). Approaches have included widening separation between in-and out-of-distribution examples via temperature scaling [Liang et al., 2017] , or by encouraging uniform output distributions for unseen examples , Dhamija et al., 2018 . Other work has looked at estimating predictive uncertainty from deep networks, either by averaging Monte Carlo samples of examples passed through a dropout network [Gal and Ghahramani, 2016] , or by training ensembles [Lakshminarayanan et al., 2017] .
Ensemble and Federated Learning. Learning ensembles of models for improving performance and robustness has a long tradition in machine learning [c.f. Dietterich [2000] ]. Popular strategies have included learning adaptive mixtures of experts [Jacobs et al., 1991] , and adaptive boosting algorithms [Collins et al., 2002] . More recently, a related area of interest has been federated learning of models from siloed data providers [Li et al., 2019] in a distributed and privacy-preserving manner, and recent work has studied this in the context of a healthcare application.
In this work, we combine these three threads, and explore methods to learn diagnosis models with reject options under both centralized and federated settings.
Conclusion
In this work we study machine-learned diagnosis as an open-set learning problem where the model must additionally learn to not diagnose when faced with a previously unseen condition. We apply modern methods to this problem in two settings -first with centralized training data and the second with distributed data across sites that do not permit data-pooling. Across settings, we observe gains from modeling unknown conditions, but find different strategies to be optimal in different settings.
Our work has certain limitations that we will seek to overcome in future work. Firstly, we observe that softmax scores from our diagnostic models tend to be highly peaky, and models will likely benefit from calibration. Further, we only assume identical model families and architectures across sites, whereas in practice we would like to relax this assumption, and potentially ensemble rule-based diagnostic engines with learned systems. In this work we restrict our evaluation to simulated data, and a natural extension would be to benchmark our approach on real-world clinical case data. Finally, we do not model distribution shift, both across sites, and between experts and deployment, both of which are essential challenges to overcome on the road to building reliable diagnostic models.
